Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy?

Moreover, there lies a certain “tier” of funds that elected to cut their entire stakes heading into Q4. It’s worth mentioning that James E. Flynn’s Deerfield Management dumped the biggest position of the “upper crust” of funds watched by Insider Monkey, worth about $7.9 million in stock. Mark Kingdon’s fund, Kingdon Capital, also sold off its stock, about $3.6 million worth.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) but similarly valued. These stocks are TG Therapeutics Inc (NASDAQ:TGTX), National Interstate Corporation (NASDAQ:NATL), Green Brick Partners Inc (NASDAQ:GRBK), and Western Asset Mortgage Capital Corp (NYSE:WMC). This group of stocks’ market caps match AMPH’s market cap.

As you can see these stocks had an average of 7 hedge funds with bullish positions and the average amount invested in these stocks was $134 million, compared to $26 million in AMPH’s case. TG Therapeutics Inc (NASDAQ:TGTX) is the most popular stock in this table with a total of 10 funds reporting long positions. On the other hand Western Asset Mortgage Capital Corp (NYSE:WMC) is the least popular one with only 4 bullish hedge fund positions. Compared to these stocks Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.